HUP0200547A2 - Eljárás intravénás ösztramusztin-foszfát potencirozására szolgáló gyógyszerkészítmények előállítására - Google Patents
Eljárás intravénás ösztramusztin-foszfát potencirozására szolgáló gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0200547A2 HUP0200547A2 HU0200547A HUP0200547A HUP0200547A2 HU P0200547 A2 HUP0200547 A2 HU P0200547A2 HU 0200547 A HU0200547 A HU 0200547A HU P0200547 A HUP0200547 A HU P0200547A HU P0200547 A2 HUP0200547 A2 HU P0200547A2
- Authority
- HU
- Hungary
- Prior art keywords
- potentiate
- methods
- pharmaceutical compositions
- estramustine phosphate
- producing pharmaceutical
- Prior art date
Links
- 229960004750 estramustine phosphate Drugs 0.000 title 1
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7954298P | 1998-03-27 | 1998-03-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200547A2 true HUP0200547A2 (hu) | 2002-07-29 |
| HUP0200547A3 HUP0200547A3 (en) | 2003-07-28 |
Family
ID=22151209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200547A HUP0200547A3 (en) | 1998-03-27 | 1999-03-26 | Methods for producing pharmaceutical compositions to potentiate intravenous estramustine phosphate |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1003521A4 (hu) |
| JP (1) | JP2001508810A (hu) |
| KR (1) | KR20010021656A (hu) |
| CN (2) | CN1273530A (hu) |
| AU (1) | AU750010B2 (hu) |
| BR (1) | BR9906425A (hu) |
| CA (1) | CA2295049A1 (hu) |
| EA (1) | EA004647B1 (hu) |
| HU (1) | HUP0200547A3 (hu) |
| ID (1) | ID24504A (hu) |
| IL (1) | IL133612A0 (hu) |
| NO (1) | NO20002343L (hu) |
| NZ (1) | NZ501987A (hu) |
| PL (1) | PL342969A1 (hu) |
| WO (1) | WO1999049869A1 (hu) |
| ZA (1) | ZA997821B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003201D0 (en) * | 2000-02-11 | 2000-04-05 | Pharmacia & Upjohn Spa | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| US6436913B1 (en) * | 2000-07-25 | 2002-08-20 | Pharmacia & Upjohn Company | Use of estramustine phosphate in the treatment of bone metastasis |
| RU2471511C1 (ru) * | 2011-05-04 | 2013-01-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) | Способ лечения метастазов в печень рака толстой кишки |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS617292A (ja) * | 1984-06-20 | 1986-01-13 | Japan Atom Energy Res Inst | 制癌剤を結合させたエストラサイト系化合物を製造する方法 |
| US5077056A (en) * | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| WO1993018751A1 (en) * | 1992-03-23 | 1993-09-30 | Georgetown University | Liposome encapsulated taxol and a method of using the same |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
-
1999
- 1999-03-26 EA EA199901081A patent/EA004647B1/ru not_active IP Right Cessation
- 1999-03-26 CA CA002295049A patent/CA2295049A1/en not_active Abandoned
- 1999-03-26 ID IDW20000105A patent/ID24504A/id unknown
- 1999-03-26 JP JP54936999A patent/JP2001508810A/ja not_active Ceased
- 1999-03-26 BR BR9906425-1A patent/BR9906425A/pt not_active IP Right Cessation
- 1999-03-26 CN CN99800823A patent/CN1273530A/zh active Pending
- 1999-03-26 CN CNA2004100867183A patent/CN1636598A/zh active Pending
- 1999-03-26 AU AU33533/99A patent/AU750010B2/en not_active Ceased
- 1999-03-26 EP EP99914884A patent/EP1003521A4/en not_active Withdrawn
- 1999-03-26 KR KR1020007000214A patent/KR20010021656A/ko not_active Application Discontinuation
- 1999-03-26 HU HU0200547A patent/HUP0200547A3/hu unknown
- 1999-03-26 NZ NZ501987A patent/NZ501987A/xx unknown
- 1999-03-26 IL IL13361299A patent/IL133612A0/xx not_active IP Right Cessation
- 1999-03-26 PL PL99342969A patent/PL342969A1/xx unknown
- 1999-03-26 WO PCT/US1999/004275 patent/WO1999049869A1/en not_active Application Discontinuation
- 1999-12-22 ZA ZA9907821A patent/ZA997821B/xx unknown
-
2000
- 2000-05-04 NO NO20002343A patent/NO20002343L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1636598A (zh) | 2005-07-13 |
| NO20002343D0 (no) | 2000-05-04 |
| WO1999049869A1 (en) | 1999-10-07 |
| CN1273530A (zh) | 2000-11-15 |
| PL342969A1 (en) | 2001-07-16 |
| IL133612A0 (en) | 2001-04-30 |
| EA004647B1 (ru) | 2004-06-24 |
| CA2295049A1 (en) | 1999-10-07 |
| EP1003521A1 (en) | 2000-05-31 |
| NO20002343L (no) | 2000-05-04 |
| JP2001508810A (ja) | 2001-07-03 |
| AU750010B2 (en) | 2002-07-11 |
| NZ501987A (en) | 2002-10-25 |
| ZA997821B (en) | 2000-08-01 |
| EA199901081A1 (ru) | 2000-12-25 |
| ID24504A (id) | 2000-07-20 |
| AU3353399A (en) | 1999-10-18 |
| KR20010021656A (ko) | 2001-03-15 |
| HUP0200547A3 (en) | 2003-07-28 |
| BR9906425A (pt) | 2000-07-11 |
| EP1003521A4 (en) | 2003-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302492A3 (en) | Methods and compositions for the prevention of tolerance to medications | |
| HU9901606D0 (en) | Pharmaceutical compositions | |
| HUP9900120A3 (en) | Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0002512A3 (en) | Medicinal compositions for application to mucosa | |
| GB9827996D0 (en) | Pharmaceutical Compositions | |
| PL343627A1 (en) | Medicinal compositions | |
| HU9802180D0 (en) | Process for producing pharmaceutical compositions | |
| GB9809213D0 (en) | Pharmaceutical compositions | |
| HUP0101256A2 (hu) | Antitumor hatású gyógyszerkészítmény és eljárás előállítására | |
| HUP0200547A3 (en) | Methods for producing pharmaceutical compositions to potentiate intravenous estramustine phosphate | |
| ZA9810357B (en) | Use of ketolides for the preparation of pharmaceutical compositions intended to prevent arterial thrombotic complications linked with atherosclerosis. | |
| AU5763400A (en) | Methods and compositions for producing 5' enriched cdna libraries | |
| GB9802472D0 (en) | Pharmaceutical compositions | |
| HU9801925D0 (en) | Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons | |
| AU7773900A (en) | Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds | |
| AU2002218494A1 (en) | Medicinal compositions and process for producing the same | |
| HUP9800623A3 (en) | Application of (+)-o-demethyl-tramadol for production of oral analgesic pharmaceutical compositions | |
| GB9806487D0 (en) | Pharmaceutical compositions | |
| HUP0001499A3 (en) | Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis | |
| HU9800367D0 (en) | Antiviral pharmaceutical compositions and process for producing them | |
| HUT71805A (en) | Process for producing pharmaceutical compositions having inhibition celle-proliferation effect | |
| HU9902478D0 (en) | Antiviral pharmaceutical compositions and process for producing thereof | |
| HU9401741D0 (en) | Process for producing antiviral pharmaceutical compositions | |
| HU9801085D0 (en) | Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component | |
| PL331908A1 (en) | Method of producing three-dimensional graphical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |